Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011

The aim of this study is to determine the survival of live births with trisomy 18 and trisomy 13 and their variants. Information on live births with trisomy 18 or trisomy 13 recorded in the National Down Syndrome Cytogenetic Register (NDSCR) was linked by the NHS Information Centre to obtain informa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of medical genetics. Part A 2013-10, Vol.161A (10), p.2512-2518
Hauptverfasser: Wu, Jianhua, Springett, Anna, Morris, Joan K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2518
container_issue 10
container_start_page 2512
container_title American journal of medical genetics. Part A
container_volume 161A
creator Wu, Jianhua
Springett, Anna
Morris, Joan K.
description The aim of this study is to determine the survival of live births with trisomy 18 and trisomy 13 and their variants. Information on live births with trisomy 18 or trisomy 13 recorded in the National Down Syndrome Cytogenetic Register (NDSCR) was linked by the NHS Information Centre to obtain information about survival. Survival was known for 326 (88%) of live births with trisomy 18 and 142 (82%) of live births with trisomy 13 born in England and Wales between 2004 and 2011. The median survival time for live births with full trisomy 18 was 14 days and with full trisomy 13 was 10 days, the 3‐month survival was 20% and 18%, respectively, and the 1‐year survival for both syndromes was 8%. The 1‐year survival for live births with trisomy 18 mosaicism (n = 17) was 70%, for those with trisomy 13 mosaicism (n = 5) was 80% and for those with partial trisomy 13 (Robertsonian translocations) (n = 17) was 29%. This study is based on the largest data set on survival for live births with trisomy 18 and trisomy 13. Although median survival for these children is 2 weeks or less, about one in five survive for 3 months or more and about 1 in 12 survive for 1 year or more. We suggest that these survival rates are used in counselling as well as the median survival time. © 2013 Wiley Periodicals, Inc.
doi_str_mv 10.1002/ajmg.a.36127
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1492613911</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3156400911</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5727-576ec59d648d8761213dcf6e208307f5707ce9c2185c2041cfd3ee6124047e8a3</originalsourceid><addsrcrecordid>eNqN0U1rVDEUBuAgiq3VnWsJuBnBO558J90NZTpVahWqjLsQk9xyx_tRk7mt8-_NOO0ILqSLkECecziHF6GXBKYEgL5zq-5q6qZMEqoeoUMiBK24Zuzx_k3FAXqW8wqAgVDyKTqgzHBjKD9EzeWYbpob1-KhxuvU5KHbYKLxZB5uXQoZ500f0tDFN9j14a9gePLZrd2IL_f_TY_n_VW7ZduzdG3Mx5gC8IoCIc_Rk9q1Ob64u4_Q19P5l5Oz6vzT4v3J7LzyQlFVlQGjFyZIroNWZSnCgq9lpKAZqFooUD4aT4kWngInvg4sxuI4cBW1Y0dosut7nYafY8xr2zXZx7YMFocxW8INlYQZQh5AhRbUaG4eQJkW0kimCn39D10NY-rLzkVJDWAkFUW93SmfhpxTrO11ajqXNpaA3QZrt8FaZ_8EW_iru6bj9y6GPb5PsgC-A7dNGzf_bWZnHz4uZvd9q11Zk9fx177MpR9WKqaEXV4s7De1WMqLM2NP2W9ARbiF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1468009625</pqid></control><display><type>article</type><title>Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Wu, Jianhua ; Springett, Anna ; Morris, Joan K.</creator><creatorcontrib>Wu, Jianhua ; Springett, Anna ; Morris, Joan K.</creatorcontrib><description>The aim of this study is to determine the survival of live births with trisomy 18 and trisomy 13 and their variants. Information on live births with trisomy 18 or trisomy 13 recorded in the National Down Syndrome Cytogenetic Register (NDSCR) was linked by the NHS Information Centre to obtain information about survival. Survival was known for 326 (88%) of live births with trisomy 18 and 142 (82%) of live births with trisomy 13 born in England and Wales between 2004 and 2011. The median survival time for live births with full trisomy 18 was 14 days and with full trisomy 13 was 10 days, the 3‐month survival was 20% and 18%, respectively, and the 1‐year survival for both syndromes was 8%. The 1‐year survival for live births with trisomy 18 mosaicism (n = 17) was 70%, for those with trisomy 13 mosaicism (n = 5) was 80% and for those with partial trisomy 13 (Robertsonian translocations) (n = 17) was 29%. This study is based on the largest data set on survival for live births with trisomy 18 and trisomy 13. Although median survival for these children is 2 weeks or less, about one in five survive for 3 months or more and about 1 in 12 survive for 1 year or more. We suggest that these survival rates are used in counselling as well as the median survival time. © 2013 Wiley Periodicals, Inc.</description><identifier>ISSN: 1552-4825</identifier><identifier>EISSN: 1552-4833</identifier><identifier>DOI: 10.1002/ajmg.a.36127</identifier><identifier>PMID: 23949924</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Children ; Chromosome Disorders - mortality ; Chromosomes, Human, Pair 13 ; Chromosomes, Human, Pair 18 ; England - epidemiology ; Female ; Humans ; Male ; mosaicism ; Registries ; Risk Factors ; Robertsonian translocation ; survival ; Survival Analysis ; Trisomy ; trisomy 13 ; Trisomy 13 Syndrome ; trisomy 18 ; Trisomy 18 Syndrome ; Wales - epidemiology</subject><ispartof>American journal of medical genetics. Part A, 2013-10, Vol.161A (10), p.2512-2518</ispartof><rights>Copyright © 2013 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5727-576ec59d648d8761213dcf6e208307f5707ce9c2185c2041cfd3ee6124047e8a3</citedby><cites>FETCH-LOGICAL-c5727-576ec59d648d8761213dcf6e208307f5707ce9c2185c2041cfd3ee6124047e8a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajmg.a.36127$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajmg.a.36127$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23949924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wu, Jianhua</creatorcontrib><creatorcontrib>Springett, Anna</creatorcontrib><creatorcontrib>Morris, Joan K.</creatorcontrib><title>Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011</title><title>American journal of medical genetics. Part A</title><addtitle>Am. J. Med. Genet</addtitle><description>The aim of this study is to determine the survival of live births with trisomy 18 and trisomy 13 and their variants. Information on live births with trisomy 18 or trisomy 13 recorded in the National Down Syndrome Cytogenetic Register (NDSCR) was linked by the NHS Information Centre to obtain information about survival. Survival was known for 326 (88%) of live births with trisomy 18 and 142 (82%) of live births with trisomy 13 born in England and Wales between 2004 and 2011. The median survival time for live births with full trisomy 18 was 14 days and with full trisomy 13 was 10 days, the 3‐month survival was 20% and 18%, respectively, and the 1‐year survival for both syndromes was 8%. The 1‐year survival for live births with trisomy 18 mosaicism (n = 17) was 70%, for those with trisomy 13 mosaicism (n = 5) was 80% and for those with partial trisomy 13 (Robertsonian translocations) (n = 17) was 29%. This study is based on the largest data set on survival for live births with trisomy 18 and trisomy 13. Although median survival for these children is 2 weeks or less, about one in five survive for 3 months or more and about 1 in 12 survive for 1 year or more. We suggest that these survival rates are used in counselling as well as the median survival time. © 2013 Wiley Periodicals, Inc.</description><subject>Children</subject><subject>Chromosome Disorders - mortality</subject><subject>Chromosomes, Human, Pair 13</subject><subject>Chromosomes, Human, Pair 18</subject><subject>England - epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>mosaicism</subject><subject>Registries</subject><subject>Risk Factors</subject><subject>Robertsonian translocation</subject><subject>survival</subject><subject>Survival Analysis</subject><subject>Trisomy</subject><subject>trisomy 13</subject><subject>Trisomy 13 Syndrome</subject><subject>trisomy 18</subject><subject>Trisomy 18 Syndrome</subject><subject>Wales - epidemiology</subject><issn>1552-4825</issn><issn>1552-4833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0U1rVDEUBuAgiq3VnWsJuBnBO558J90NZTpVahWqjLsQk9xyx_tRk7mt8-_NOO0ILqSLkECecziHF6GXBKYEgL5zq-5q6qZMEqoeoUMiBK24Zuzx_k3FAXqW8wqAgVDyKTqgzHBjKD9EzeWYbpob1-KhxuvU5KHbYKLxZB5uXQoZ500f0tDFN9j14a9gePLZrd2IL_f_TY_n_VW7ZduzdG3Mx5gC8IoCIc_Rk9q1Ob64u4_Q19P5l5Oz6vzT4v3J7LzyQlFVlQGjFyZIroNWZSnCgq9lpKAZqFooUD4aT4kWngInvg4sxuI4cBW1Y0dosut7nYafY8xr2zXZx7YMFocxW8INlYQZQh5AhRbUaG4eQJkW0kimCn39D10NY-rLzkVJDWAkFUW93SmfhpxTrO11ajqXNpaA3QZrt8FaZ_8EW_iru6bj9y6GPb5PsgC-A7dNGzf_bWZnHz4uZvd9q11Zk9fx177MpR9WKqaEXV4s7De1WMqLM2NP2W9ARbiF</recordid><startdate>201310</startdate><enddate>201310</enddate><creator>Wu, Jianhua</creator><creator>Springett, Anna</creator><creator>Morris, Joan K.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201310</creationdate><title>Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011</title><author>Wu, Jianhua ; Springett, Anna ; Morris, Joan K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5727-576ec59d648d8761213dcf6e208307f5707ce9c2185c2041cfd3ee6124047e8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Children</topic><topic>Chromosome Disorders - mortality</topic><topic>Chromosomes, Human, Pair 13</topic><topic>Chromosomes, Human, Pair 18</topic><topic>England - epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>mosaicism</topic><topic>Registries</topic><topic>Risk Factors</topic><topic>Robertsonian translocation</topic><topic>survival</topic><topic>Survival Analysis</topic><topic>Trisomy</topic><topic>trisomy 13</topic><topic>Trisomy 13 Syndrome</topic><topic>trisomy 18</topic><topic>Trisomy 18 Syndrome</topic><topic>Wales - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wu, Jianhua</creatorcontrib><creatorcontrib>Springett, Anna</creatorcontrib><creatorcontrib>Morris, Joan K.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of medical genetics. Part A</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wu, Jianhua</au><au>Springett, Anna</au><au>Morris, Joan K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011</atitle><jtitle>American journal of medical genetics. Part A</jtitle><addtitle>Am. J. Med. Genet</addtitle><date>2013-10</date><risdate>2013</risdate><volume>161A</volume><issue>10</issue><spage>2512</spage><epage>2518</epage><pages>2512-2518</pages><issn>1552-4825</issn><eissn>1552-4833</eissn><abstract>The aim of this study is to determine the survival of live births with trisomy 18 and trisomy 13 and their variants. Information on live births with trisomy 18 or trisomy 13 recorded in the National Down Syndrome Cytogenetic Register (NDSCR) was linked by the NHS Information Centre to obtain information about survival. Survival was known for 326 (88%) of live births with trisomy 18 and 142 (82%) of live births with trisomy 13 born in England and Wales between 2004 and 2011. The median survival time for live births with full trisomy 18 was 14 days and with full trisomy 13 was 10 days, the 3‐month survival was 20% and 18%, respectively, and the 1‐year survival for both syndromes was 8%. The 1‐year survival for live births with trisomy 18 mosaicism (n = 17) was 70%, for those with trisomy 13 mosaicism (n = 5) was 80% and for those with partial trisomy 13 (Robertsonian translocations) (n = 17) was 29%. This study is based on the largest data set on survival for live births with trisomy 18 and trisomy 13. Although median survival for these children is 2 weeks or less, about one in five survive for 3 months or more and about 1 in 12 survive for 1 year or more. We suggest that these survival rates are used in counselling as well as the median survival time. © 2013 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>23949924</pmid><doi>10.1002/ajmg.a.36127</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-4825
ispartof American journal of medical genetics. Part A, 2013-10, Vol.161A (10), p.2512-2518
issn 1552-4825
1552-4833
language eng
recordid cdi_proquest_miscellaneous_1492613911
source MEDLINE; Access via Wiley Online Library
subjects Children
Chromosome Disorders - mortality
Chromosomes, Human, Pair 13
Chromosomes, Human, Pair 18
England - epidemiology
Female
Humans
Male
mosaicism
Registries
Risk Factors
Robertsonian translocation
survival
Survival Analysis
Trisomy
trisomy 13
Trisomy 13 Syndrome
trisomy 18
Trisomy 18 Syndrome
Wales - epidemiology
title Survival of trisomy 18 (Edwards syndrome) and trisomy 13 (Patau Syndrome) in England and Wales: 2004-2011
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A43%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survival%20of%20trisomy%2018%20(Edwards%20syndrome)%20and%20trisomy%2013%20(Patau%20Syndrome)%20in%20England%20and%20Wales:%202004-2011&rft.jtitle=American%20journal%20of%20medical%20genetics.%20Part%20A&rft.au=Wu,%20Jianhua&rft.date=2013-10&rft.volume=161A&rft.issue=10&rft.spage=2512&rft.epage=2518&rft.pages=2512-2518&rft.issn=1552-4825&rft.eissn=1552-4833&rft_id=info:doi/10.1002/ajmg.a.36127&rft_dat=%3Cproquest_cross%3E3156400911%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1468009625&rft_id=info:pmid/23949924&rfr_iscdi=true